Know Cancer

or
forgot password
  • cancer clinical trials in valhalla, NY

  • Thalidomide in Treating Patients With Gynecologic Sarcomas
    New York Medical College
    Valhalla, New York 10595
    Endometrial Cancer, Sarcoma
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    New York Medical College
    Valhalla, New York 10595
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    New York Medical College
    Valhalla, New York 10595
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    New York Medical College
    Valhalla, New York 10595
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
    New York Medical College
    Valhalla, New York 10595
    Leukemia
    Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
    New York Medical College
    Valhalla, New York 10595
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    New York Medical College
    Valhalla, New York 10595
    Brain and Central Nervous System Tumors
    Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
    New York Medical College
    Valhalla, New York 10595
    Brain Tumor, Central Nervous System Tumor
    Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
    New York Medical College
    Valhalla, New York 10595
    Graft Versus Host Disease
    A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
    Westchester County Medical Center
    Valhalla, New York 10595
    Myelodysplastic Syndromes
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    New York Medical College
    Valhalla, New York 10595
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    New York Medical College
    Valhalla, New York 10595
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
    New York Medical College
    Valhalla, New York 10595
    Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Oral Complications, Sarcoma
    Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
    New York Medical College
    Valhalla, New York 10595
    Glioblastoma Multiforme
    XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
    New York Medical College
    Valhalla, New York 10595
    Biliary Tract Cancer
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    New York Medical College
    Valhalla, New York 10595
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    New York Medical College
    Valhalla, New York 10595
    Brain and Central Nervous System Tumors
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    New York Medical College
    Valhalla, New York 10595
    Brain and Central Nervous System Tumors
    Study of TPI 287 in Patients With Advanced Malignancies
    New York Medical College
    Valhalla, New York 10595
    Neoplasms, Non-Hodgkin Lymphoma, Hodgkin Disease
    Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
    New York Medical College
    Valhalla, New York 10595
    Graft vs Host Disease
    Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
    New York Medical College
    Valhalla, New York 10595
    Tumor Lysis Syndrome, Cancer, Hyperuricemia
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    New York Medical College
    Valhalla, New York 10595
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
    New York Medical College
    Valhalla, New York 10595
    Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Disseminated Neuroblastoma, Juvenile Myelomonocytic Leukemia, Previously Treated Childhood Rhabdomyosarcoma, Previously Treated Myelodysplastic Syndromes, Pulmonary Complications, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Neuroblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    New York Medical College
    Valhalla, New York 10595
    Neuroblastoma
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    New York Medical College
    Valhalla, New York 10595
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    New York Medical College
    Valhalla, New York 10595
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies
    Mew York Medical College, Division of Oncology
    Valhalla, New York 10595
    Hematologic Malignancies, AML
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    New York Medical College
    Valhalla, New York 10595
    Leukemia
    Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
    New York Medical College
    Valhalla, New York 10595
    Acute Lymphoblastic Leukemia (ALL)
    BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
    1200.23.013 Boehringer Ingelheim Investigational Site
    Valhalla, New York
    Carcinoma, Non-Small-Cell Lung
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    New York Medical College
    Valhalla, New York 10595
    Relapsed Follicular Lymphoma
    Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
    New York Medical College
    Valhalla, New York 10595
    Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura
    A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
    New York Medical College
    Valhalla, New York 10595
    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell
    Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
    New York Medical College, Division of Oncology
    Valhalla, New York 10595
    Acute Myeloid Leukemia
    Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
    New York Medical College
    Valhalla, New York 10595
    Acute Myeloid Leukemia
    Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
    New York Medical College
    Valhalla, New York 10595
    Transfusional Hemosiderosis
    Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)
    New York Medical College
    Valhalla, New York 10595
    Metastatic Androgen Independent Prostate Cancer
    Elitek (Rasburicase) Immuno-Monitoring Study
    Investigational Site Number 3
    Valhalla, New York 10595
    Tumor Lysis Syndrome
    Collection of Bone Marrow From Donors Treated With or Without Filgrastim
    New York Medical College
    Valhalla, New York 10595
    Healthy, no Evidence of Disease
    Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients
    Department of Pediatrics
    Valhalla, New York 10595
    Chemotherapy-Induced Nausea and Vomiting